CHARLOTTESVILLE, VA – (July 7, 2016) – The Focused Ultrasound Foundation has recruited Emily White, MD, to serve as Director of Operations. Dr. White will lead an ongoing effort to increase efficiency and effectiveness throughout the organization.
“I’m honored to be a part of the Foundation team. This is a dynamic, fast paced organization with a broad agenda, and my work will help to streamline existing programs as well as initiate critical new efforts,” says Dr. White.
“Emily is the perfect fit for our mission to save time and save lives,” adds Neal F. Kassell, MD, Chairman of the Focused Ultrasound Foundation. “Her extensive background in clinical medicine, technical start-ups, non-profit management, business development, grant writing and surgical oncology research will add tremendous value as she interfaces with all aspects of the Foundation’s operations.”
Prior to joining the Foundation, Dr. White was a private consultant working in operations and business development support in the healthcare and medical start-up space. Her clients have included everything from a 4,000+ employee, publically traded, health care company to a brand new start-up with two employees. Her background includes training in general surgery, leadership positions in several highly technical start-up companies with federal clients, non-profit executive management and over 25 years of grant writing experience. She completed her undergraduate degree in Biology & Anthropology at Smith College, holds certification for Community Conflict Resolution from Loyola Law School, and is a University of Virginia School of Medicine graduate.
About Focused Ultrasound
Focused ultrasound uses ultrasonic energy guided by real-time imaging to treat tissue deep in the body without incisions or radiation. Multiple intersecting beams of ultrasound are directed and concentrated on a target; much like a magnifying glass can focus multiple beams of light on a single point. Where each individual beam passes through the tissue, there is no effect. But, at the focal point, the convergence of the beams of focused ultrasound energy results in many important biological effects depending on the nature of the tissue and the ultrasound parameters.
Today, focused ultrasound is approved in the United States to treat uterine fibroids, reduce pain from bone metastases, and treat the prostate. The technology is in various stages of research and development for more than 50 diseases, including Parkinson’s, Alzheimer’s, hypertension, and tumors of the brain, liver, breast, and pancreas.
About the Focused Ultrasound Foundation
The Focused Ultrasound Foundation was created to improve the lives of millions of people worldwide by accelerating the development of focused ultrasound. Working to clear the path to global adoption, the Foundation coordinates and funds research, fosters collaboration, and builds awareness. The Foundation is dedicated to ensuring that focused ultrasound finds its place as a mainstream therapy for a range of conditions within years, not decades. Since its establishment in 2006, the Foundation has become the largest non-governmental source of funding for focused ultrasound research. More information can be found at http://www.fusfoundation.org.